-
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding RiskP Urban, R Mehran, R Colleran et al. -
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAIGP Frederick, AJ Kirtane and American College of Cardiology’s Interventional Council and the Society for Cardiovascular Angiography and Interventions.
-
Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN CTO RegistryT Hirai, M Qintar, on behalf of the OPEN CTO Study Group et al.
-
Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation The mSToPS Randomized Clinical TrialSR Steinhubl, J Waalen, AM Edwards et al.
-
Coronary Angiography after Cardiac Arrest — The Right Timing or the Right Patients?BS Abella, DF Gaieski.
-
Classification of Deaths in Cardiovascular Outcomes Trials Known Unknowns and Unknown UnknownsMorrow DA, Wiviott SD.
-
2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization)GJ Dehmer, V Badhwar, EA Bermude et al.
-
Percutaneous Coronary Intervention Readmissions Where Are the Solutions?Kalra A, Shishehbor MH, Simon DI.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
